Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer.

Mitsuro KandaYuuya KasaharaDai ShimizuTakahiro ShinozukaMasahiro SasaharaShunsuke NakamuraYohei IguchiMasahisa KatsunoYasuhiro KoderaSatoshi Obika

Published in: British journal of cancer (2024)

AmNA-modified anti-PCDHA11 ASOs offer a promising therapeutic strategy for the treatment of gastric cancer and other solid malignancies.

Keyphrases